Enrolling by invitationNot applicableNCT06940193

A Self-test Home-use Blood Phenylalanine Monitoring System Under the Brand Name Egoo Phe System Has Been Developed for Measurement of Phenylalanine (Phe) in Individuals Diagnosed With Phenylketonuria (PKU): The Study Purpose is to Evaluate Accuracy and Usability

Studying Phenylketonuria

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Egoo Health Aps
Principal Investigator
Anita MacDonald
Birmingham Women's and Children's NHS Foundation Trust
Enrollment
20 enrolled
Eligibility
3 years · All sexes
Timeline
20252025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06940193 on ClinicalTrials.gov

Other trials for Phenylketonuria

Additional recruiting or active studies for the same condition.

See all trials for Phenylketonuria

← Back to all trials